 | |
| Clinical data | |
|---|---|
| AHFS/ Drugs.com | International Drug Names |
| ATCvet code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard ( EPA) | |
| ECHA InfoCard | 100.055.387 |
| Chemical and physical data | |
| Formula | C18H22N2O2 |
| Molar mass | 298.386 g·mol−1 |
| 3D model ( JSmol) | |
| |
Carazolol is a high affinity inverse agonist (also referred to as a beta blocker) of the β- adrenergic receptor. [1]
References
- ^ Innis RB, Corrēa FM, Synder SH (1979). "Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes". Life Sci. 24 (24): 2255–64. doi: 10.1016/0024-3205(79)90102-4. PMID 41147.
External links
- Carazolol at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
|
| |
| Clinical data | |
|---|---|
| AHFS/ Drugs.com | International Drug Names |
| ATCvet code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard ( EPA) | |
| ECHA InfoCard | 100.055.387 |
| Chemical and physical data | |
| Formula | C18H22N2O2 |
| Molar mass | 298.386 g·mol−1 |
| 3D model ( JSmol) | |
| |
Carazolol is a high affinity inverse agonist (also referred to as a beta blocker) of the β- adrenergic receptor. [1]
References
- ^ Innis RB, Corrēa FM, Synder SH (1979). "Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes". Life Sci. 24 (24): 2255–64. doi: 10.1016/0024-3205(79)90102-4. PMID 41147.
External links
- Carazolol at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
|
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |